Questions by U.S. regulators regarding the Sanofi device designed to deliver its Lantus-plus-lixisenatide combo to combat diabetes has pushed an approval…

Not enough drugmakers on the “smart inhaler” bandwagon for you? Well, go ahead and add AstraZeneca to the list.

Eye care company pSivida said topline results from its Phase III trial of Medidur, designed to treat chronic noninfectious uveitis, exceeded its expectations.…

Flamel has launched U.S. distribution of its recently FDA-approved hypotension drug Akovaz, adding that its shareholders approved reincorporation in Ireland,…

German diabetes specialist Emperra has launched the first wireless insulin pen that transfers data to a patient’s blood glucose diary via Bluetooth.

SkinJect, a Pittsburgh-based device company, said it reached a deal with the University of Pittsburgh to license a minimally invasive treatment for common…

The JDRF, a global research foundation focused on Type 1 diabetes, and Arecor said they are partnering to advance preclinical trials of the U.K.-based…

Florida’s HedgePath Pharmaceuticals heralded a positive midstage study for its oral capsules designed to treat a complication associated with basal cell…